Insider trading · Q3 2026 · CIK 1842295

Maze Therapeutics, Inc. (MAZE) insider trading.

Name: Maze Therapeutics, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Maze Therapeutics, Inc. reported 44 non-derivative transactions on 20 Forms 3, 4 and 5: 0 open-market purchases and 34 sales worth $6.2M.

Transactions: 44
Purchases (P): 0
Sales (S): 34
Net shares, P minus S: -225,960
Insiders: 4
Last filed: 2026-09-08

Insiders

Insider	Relationship	Transactions	Sales
Coloma Jason V	Director, Officer · Chief Executive Officer	14	13
Bernstein Harold	Officer · President, R&D & CMO	13	9
Dandekar Atul	Officer · CSBO	12	8
Courtney Phillips	Officer · GC and Corp. Secretary	5	4

Transactions

44 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-04	Bernstein Harold	S (D)	9,705	$26.22	0	Form 4
2026-09-03	Coloma Jason V	S (D)	129	$25.77	27,362	Form 4
2026-09-03	Coloma Jason V	S (D)	11,282	$26.01	27,491	Form 4
2026-09-03	Courtney Phillips	S (D)	1,990	$26.01	7,029	Form 4
2026-09-03	Courtney Phillips	S (D)	22	$25.78	7,007	Form 4
2026-09-03	Dandekar Atul	S (D)	3,207	$26.01	32,352	Form 4
2026-09-03	Dandekar Atul	S (D)	36	$25.81	32,316	Form 4
2026-09-03	Bernstein Harold	S (D)	59	$25.78	9,705	Form 4
2026-09-03	Bernstein Harold	S (D)	5,130	$26.01	9,764	Form 4
2026-09-02	Coloma Jason V	S (D)	1,375	$27.12	38,773	Form 4
2026-09-02	Coloma Jason V	S (D)	9,852	$26.38	40,148	Form 4
2026-09-02	Courtney Phillips	S (D)	243	$27.12	9,019	Form 4
2026-09-02	Courtney Phillips	S (D)	1,738	$26.38	9,262	Form 4
2026-09-02	Dandekar Atul	S (D)	2,800	$26.38	35,950	Form 4
2026-09-02	Dandekar Atul	S (D)	391	$27.12	35,559	Form 4
2026-09-02	Bernstein Harold	S (D)	625	$27.12	14,894	Form 4
2026-09-02	Bernstein Harold	S (D)	4,481	$26.38	15,519	Form 4
2026-09-01	Coloma Jason V	S (D)	2,593	$26.31	18,151	Form 4
2026-09-01	Coloma Jason V	M (A)	50,000	$0	50,000	Form 4
2026-09-01	Coloma Jason V	S (D)	31,908	$26.29	223,355	Form 4
2026-09-01	Courtney Phillips	M (A)	11,000	$0	11,000	Form 4
2026-09-01	Dandekar Atul	M (A)	12,500	$0	38,750	Form 4
2026-09-01	Bernstein Harold	M (A)	16,141	$10.42	16,141	Form 4
2026-09-01	Bernstein Harold	S (D)	16,141	$26.36	0	Form 4
2026-09-01	Bernstein Harold	M (A)	20,000	$0	20,000	Form 4
2026-08-28	Dandekar Atul	S (D)	7,500	$27.58	26,250	Form 4
2026-08-28	Dandekar Atul	M (A)	7,500	$10.42	33,750	Form 4
2026-08-13	Bernstein Harold	S (D)	16,142	$27.61	0	Form 4
2026-08-13	Bernstein Harold	M (A)	16,142	$10.42	16,142	Form 4
2026-08-03	Coloma Jason V	S (D)	2,439	$26.71	20,898	Form 4
2026-08-03	Coloma Jason V	S (D)	154	$27.09	20,744	Form 4
2026-08-03	Coloma Jason V	S (D)	30,304	$26.71	256,867	Form 4
2026-08-03	Coloma Jason V	S (D)	1,604	$27.09	255,263	Form 4
2026-07-29	Dandekar Atul	M (A)	7,500	$10.42	33,750	Form 4
2026-07-29	Dandekar Atul	S (D)	400	$27.89	26,250	Form 4
2026-07-29	Dandekar Atul	S (D)	7,100	$27.31	26,650	Form 4
2026-07-01	Coloma Jason V	S (D)	1,597	$30.44	287,171	Form 4
2026-07-01	Coloma Jason V	S (D)	2,593	$29.98	23,337	Form 4
2026-07-01	Coloma Jason V	S (D)	30,311	$29.95	288,768	Form 4
2026-07-01	Bernstein Harold	S (D)	1,200	$30.34	0	Form 4
2026-07-01	Bernstein Harold	M (A)	14,609	$10.42	14,609	Form 4
2026-07-01	Bernstein Harold	S (D)	13,409	$29.87	1,200	Form 4
2026-06-29	Dandekar Atul	S (D)	7,500	$28.02	26,250	Form 4
2026-06-29	Dandekar Atul	M (A)	7,500	$10.42	33,750	Form 4

Transaction codes in this quarter

S: 34 M: 10

Get MAZE insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1842295&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · MAZE company page · Maze Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Maze Therapeutics, Inc. (MAZE)?

In Q3 2026, insiders at Maze Therapeutics, Inc. reported 44 non-derivative transactions on 20 Forms 3, 4 and 5: 0 open-market purchases and 34 sales worth $6.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Maze Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/maze.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.